This website is intended for UK healthcare professionals only Log in | Register

News and views

November 2009 Br J Cardiol 2009;16:269-71

CHD risk is being overestimated in diabetes

The Framingham and UKPDS (United Kingdom Prospective Diabetes Study) risk equations overestimate the probability of cardiovascular events in people with type 2 diabetes, according to several studies presented at the International Diabetes Federation 2009 meeting held in October in Montreal, Canada. ...

November 2009 Br J Cardiol 2009;16:269-71

New Bluetooth stethoscope available

A new stethoscope – the Littmann 3200 – is now available which is the first to enable Bluetooth transfer of sounds to software for storage and further analysis....

November 2009 Br J Cardiol 2009;16:269-71

Hypothermia improves outcomes after cardiac arrest

Conventional cooling methods can improve survival and reduce neurologic injury after cardiac arrest, a new Cochrane Review reports....

November 2009 Br J Cardiol 2009;16:269-71

BLOSSOM: new weight loss drug on the horizon

A new drug, lorcaserin, showed good weight loss results without the valvular side-effects associated with some other serotonin type agents in the Phase III Blossom (Behavioural Modification and Lorcaserin Second Study for Obesity Management) study, presented at the Obesity 2009 meeting held in October in Washington DC, USA....

November 2009 Br J Cardiol 2009;16:269-71

NT-proBNP predicts atrial fibrillation

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a “remarkable predictor” of incident atrial fibrillation (AF), even after adjustment for other known risk factors, according to the results of a new study....

November 2009 Br J Cardiol 2009;16:269-71

Increasing treatment window for tPA in stroke

New analyses of data from ECASS 3 (Third European Cooperative Acute Stroke Study) suggest that the thrombolytic, tPA (alteplase) has benefits in the treatment of stroke up to 4.5 hours after symptom onset. This builds on the current approved time window of three hours....

November 2009 Br J Cardiol 2009;16:269-71

Clopidogrel needed for more than one year after drug-eluting stent placement?

Extending clopidogrel treatment from one to two years after drug-eluting stent placement is associated with a reduction in very late thromboses, new registry data suggest. ...

November 2009 Br J Cardiol 2009;16:269-71

Niacin shows plaque regression

The use of niacin was associated with a regression of atherosclerotic plaque in a new imaging study....

November 2009 Br J Cardiol 2009;16:272

In brief

Seven million in UK have prediabetes An estimated seven million people in the UK have prediabetes (or impaired glucose regulation), according to Diabetes UK. The charity is hoping to raise … Continue reading In brief →...

November 2009 Br J Cardiol 2009;16:273 Meeting report

News from TCT 2009

The Transcatheter Cardiovascular Therapeutics 2009 meeting was held in San Francisco, USA, from September 22nd – 25th....





Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now